...
首页> 外文期刊>Mutagenesis >Comparative study in the Ames test of benzo(a)pyrene and 2-aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction.
【24h】

Comparative study in the Ames test of benzo(a)pyrene and 2-aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction.

机译:在体内或体外诱导后,使用大鼠肝S9和肝细胞进行苯并(a)re和2-氨基蒽代谢活化的Ames试验的比较研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We studied the replacement of hepatic S9 with in vivo and in vitro induced hepatocytes as a metabolic activation system with the aim of broadening the possibilities of mutagenic assays. Rats were pretreated with beta-naphthoflavone (BNF), phenobarbital (PB), 3-methylcholanthrene (MC) and a combination of BNF and PB (BNF + PB). Mutagenic activation of benzo[a]pyrene (BP) and 2-aminoanthracene (2AA) by hepatic S9 and hepatocytes was determined in the Ames test. Primary rat hepatocytes were used for in vitro induction and were used as the activating system in the Ames test. In vivo BNF treatment greatly increased the metabolic activation capacity of hepatic S9 and hepatocytes towards BP. With regard to 2AA activation, S9 and hepatocytes showed different BNF induction profiles. PB treatment reduced the mutagenicity of both compounds. Although ethoxyresorufin O-dealkylase (EROD) activity of S9 from BNF + PB-treated animals was almost 30-fold greater than the control, its effectiveness in activation of 2AA was below the control level. A large part of the EROD activity of control cells was lost during culture, together with the ability to activate 2AA, however, 72 h of MC induction increased EROD activity to 200-fold of the control, which corresponds to 28% of that of in vivo induced hepatocytes. The mutagenic potential of BP activated by in vitro induced hepatocytes was 10-fold above the control, which is 47% of the mutagenicity detected following in vivo induction. In vitro induced hepatocytes increased 2AA mutagenicity to 14.6-fold over the control, which corresponds to 68% of in vivo induction. Our results suggest that primary culture of hepatocytes provides a useful model for the study of the role of metabolic activation processes concerning enzyme activity of cytochromes P450 and other metabolic enzymes and induction profiles of different inducers.
机译:我们研究了体内和体外诱导的肝细胞作为代谢激活系统替代肝S9的目的,目的是扩大诱变测定的可能性。大鼠用β-萘黄酮(BNF),苯巴比妥(PB),3-甲基胆固醇(MC)以及BNF和PB的组合(BNF + PB)进行预处理。在Ames试验中确定了肝S9和肝细胞对苯并[a] re(BP)和2-氨基蒽(2AA)的致突变活化作用。将原代大鼠肝细胞用于体外诱导,并用作Ames测试中的激活系统。体内BNF处理大大提高了肝S9和肝细胞对BP的代谢活化能力。关于2AA激活,S9和肝细胞显示出不同的BNF诱导概况。 PB处理降低了两种化合物的诱变性。尽管来自BNF + PB处理的动物的S9的乙氧基间苯二酚O-脱烷基酶(EROD)活性几乎是对照的30倍,但其激活2AA的有效性却低于对照水平。在培养过程中,控制细胞的大部分EROD活性以及激活2AA的能力都丧失了,但是,MC诱导72小时后,EROD活性增加到对照的200倍,这相当于对照组的28%。体内诱导的肝细胞。由体外诱导的肝细胞激活的BP的诱变潜力比对照高10倍,是体内诱导后检测到的诱变性的47%。体外诱导的肝细胞将2AA的诱变性提高到对照的14.6倍,相当于体内诱导的68%。我们的结果表明,肝细胞的原代培养为研究代谢激活过程对细胞色素P450和其他代谢酶的酶活性以及不同诱导物的诱导谱的作用提供了有用的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号